From the 7/30/2021 release of VAERS data:

Found 48 cases where Vaccine targets COVID-19 (COVID19) and Manufacturer is JANSSEN and Symptom is Cardiac arrest and Patient Died

Age	Count	Percent
17-44 Years	7	14.58%
44-65 Years	18	37.5%
65-75 Years	9	18.75%
75+ Years	8	16.67%
Unknown	6	12.5%
TOTAL	48	100%

This is page 1 out of 5

VAERS ID: 1098028 (history)   Form: Version 2.0   Age: 32.0   Sex: Male   Location: New York   Vaccinated: 2021-03-13 Onset: 2021-03-14    Days after vaccination: 1 Submitted: 0000-00-00 Entered: 2021-03-14 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / - Administered by: Unknown       Purchased by: ? Symptoms: Cardiac arrest, Death SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-14    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: levothyroxine Current Illness: Preexisting Conditions: Hypothyroidism, MVP, valve repair Allergies: Diagnostic Lab Data: CDC Split Type: Write-up: Cardiac arrest, death approx 12 hours later

VAERS ID: 1103748 (history)   Form: Version 2.0   Age: 76.0   Sex: Female   Location: Alabama   Vaccinated: 2021-03-13 Onset: 2021-03-16    Days after vaccination: 3 Submitted: 0000-00-00 Entered: 2021-03-16 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM Administered by: Pharmacy       Purchased by: ? Symptoms: Cardiac arrest, Death SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-16    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: unknown Current Illness: unknown Preexisting Conditions: unknown Allergies: unknown Diagnostic Lab Data: CDC Split Type: Write-up: Cardiac Arrest/Death

VAERS ID: 1110099 (history)   Form: Version 2.0   Age: 69.0   Sex: Male   Location: Florida   Vaccinated: 2021-03-10 Onset: 2021-03-12    Days after vaccination: 2 Submitted: 0000-00-00 Entered: 2021-03-18 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 AR / IM Administered by: Unknown       Purchased by: ? Symptoms: Cardiac arrest, Resuscitation SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-12    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: Write-up: 3/12/21 Sudden cardiac arrest at home; unable to be resuscitated at scene (Brother) Caller is a family friend who was asked by family to call and report incident. If f/u is needed, please contact him first. Current Medical History: unknown by caller Current Medications: unknown by caller

VAERS ID: 1147618 (history)   Form: Version 2.0   Age: 57.0   Sex: Female   Location: New York   Vaccinated: 2021-03-22 Onset: 2021-03-29    Days after vaccination: 7 Submitted: 0000-00-00 Entered: 2021-03-30 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / - Administered by: Unknown       Purchased by: ? Symptoms: Cardiac arrest SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-29    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? No Previous Vaccinations: Other Medications: metformin, coreg, proton pump inhibitor Current Illness: Preexisting Conditions: diabetes, hypertension, alcohol use, anemia Allergies: sulfa Diagnostic Lab Data: none CDC Split Type: Write-up: cardiac arrest

VAERS ID: 1153885 (history)   Form: Version 2.0   Age:    Sex: Female   Location: New York   Vaccinated: 0000-00-00 Onset: 2021-03-11 Submitted: 0000-00-00 Entered: 2021-04-01 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / - Administered by: Other       Purchased by: ? Symptoms: Cardiac arrest, Death SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-13    Days after onset: 2 Permanent Disability? No Recovered? No Office Visit? Yes ER Visit? No ER or Doctor Visit? No Hospitalized? Yes, 2 days    Extended hospital stay? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Comments: Unknown Allergies: Diagnostic Lab Data: CDC Split Type: USJNJFOC20210329515 Write-up: ASYSTOLE; PASSED AWAY; This spontaneous report received from a physician concerned their mother-in-law, an female of unspecified age. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient was in a nursing home, but was hospitalized for pyelonephritis. The patient was not allowed back into the nursing home without a negative COVID test and the vaccine. After discharge from the hospital, the patient''s COVID test came back negative, and upon arrival to the nursing home, the patient received the Janssen COVID-19 vaccine. Within 30 minutes, the patient was unresponsive and transported back to the hospital. On arrival to the hospital, the patient was asystole. She was treated at the hospital until 13-MAR-2021, when she passed away. Asystole was reported as fatal. Additionally, cause of death was reported as "cause unknown", therefore, an additional serious adverse event of "passed away" was captured. An autopsy was not performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on 13-MAR-2021. This report was serious (Death and Hospitalization).; Sender''s Comments: V0: An female of unknown age became unresponsive 30 minutes after, experienced asystole on the same day as, and died of unknown causes 2 days after receiving Janssen COVID-19 Vaccine Ad26.COV2.S (suspension for injection; route of administration and batch number unknown) for prophylactic vaccination while in a nursing home. Medical history and concomitant medications were not reported. The patient was the mother-in-law of the reporter, an internal medicine physician. The patient had no complaints for 30 minutes after receiving the vaccine, then became unresponsive; she was transported to a hospital where she was noted to be asystolic upon arrival. Treatment and hospital course were not provided. The patient died 2 days after receiving the vaccine, and cause of death was unknown; outcome of asystole was reported as fatal. An autopsy was not performed. This case has insufficient information to make a meaningful medical assessment.; Reported Cause(s) of Death: ASYSTOLE; UNKNOWN CAUSE OF DEATH

VAERS ID: 1157494 (history)   Form: Version 2.0   Age: 53.0   Sex: Male   Location: Pennsylvania   Vaccinated: 0000-00-00 Onset: 2021-03-22 Submitted: 0000-00-00 Entered: 2021-04-01 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805022 / UNK - / - Administered by: Other       Purchased by: ? Symptoms: Cardiac arrest, Oxygen saturation SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-22    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: CEFTRIAXONE; HEPARIN Current Illness: Central line placement; Diabetic foot ulcer; Type II diabetes mellitus Preexisting Conditions: Comments: The patient had no known allergies. The patient had no previous history of heart conditions. Allergies: Diagnostic Lab Data: Test Date: 20210322; Test Name: Oxygen saturation; Result Unstructured Data: Dropped to 70''s CDC Split Type: USJNJFOC20210342361 Write-up: CARDIAC ARREST; This spontaneous report received from a consumer concerned a 53 year old male. The patient''s height, and weight were not reported. The patient''s concurrent conditions included type 2 diabetes, picc line, and diabetic foot ulcer. The patient had no known allergies. The patient had no previous history of heart conditions. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. Concomitant medications included Ceftriaxone for diabetic foot ulcer, and Heparin for picc line prophylaxis. On Saturday, 20-MAR-2021, the patient reported that his chest felt funny but he wasn''t sure about the cause. On Monday, 22-MAR-2021 morning; the patient had collapsed when he got out of the shower and yelled for help. The patient was gasping for breath and reading on pulse oximeter dropped into the 70''s and also reported that he felt light headed. It was unknown weather the patient died in ambulance or at hospital. It was unspecified if an autopsy was performed. Laboratory data included: Oxygen saturation decreased (NR: not provided) Dropped to 70''s. On 22-MAR-2021, the subject died from cardiac arrest. The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. This report was serious (Death).; Sender''s Comments: V0: 20210342361 -COVID-19 VACCINE AD26.COV2.S- Cardiac Arrest. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: MEDICAL HISTORY.; Reported Cause(s) of Death: CARDIAC ARREST

VAERS ID: 1168291 (history)   Form: Version 2.0   Age: 71.0   Sex: Male   Location: Illinois   Vaccinated: 2021-03-30 Onset: 2021-04-05    Days after vaccination: 6 Submitted: 0000-00-00 Entered: 2021-04-05 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805025 / 1 - / - Administered by: Private       Purchased by: ? Symptoms: Agonal rhythm, Blood glucose normal, Breath sounds abnormal, Cardiac arrest, Chest pain, Chronic obstructive pulmonary disease, Condition aggravated, Death, Dyspnoea, Endotracheal intubation, Mobility decreased, Oxygen saturation decreased, Physical deconditioning, Pulse absent, Pupil fixed, Resuscitation SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Angioedema (broad), Arrhythmia related investigations, signs and symptoms (broad), Conduction defects (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Parkinson-like events (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Infective pneumonia (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-04-05    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, 9 days    Extended hospital stay? No Previous Vaccinations: Other Medications: Medications Prior to Admission Medication Sig Dispense Refill Last Dose ? allopurinol (ZYLOPRIM) 300 MG tablet 2 times daily Unknown at Unknown time ? amLODIPine (NORVASC) 10 MG tablet Take 1 tablet by mouth once daily 30 tablet 0 Unk Current Illness: Preexisting Conditions: Allergies: Allergies Allergen Reactions ? Codeine ? Hydrochlorothiazide ? Maxzide [Hydrochlorothiazide W/Triamterene] Renal failure ? Nitroglycerin Blood pressure drops Diagnostic Lab Data: CDC Split Type: Write-up: 3/22/21 Admission HPI: 71 y.o. male with a history of poorly controlled diabetes mellitus and COPD. He presented to my office today acutely with a several day history of increasing shortness of breath. He has increased his prednisone at home recently and been increasing the frequency of his DuoNebs. Despite this, he states that his oxygen saturations have been staying in the low 80s. He has a hard time walking due to the shortness of breath. He states previous to about a week ago he was doing very well. He denies any fever. He denies any known exposure to coronavirus (COVID-19). In the office today his oxygen saturations were 88% on 4 L. Because of his failure of outpatient therapy, he will be admitted to the hospital for further evaluation and treatment. This patient has a history of severe respiratory decompensation that happens very quickly. Therefore, it is medically urgent we get him into the hospital. 3/25/21 Admission HPI71 y.o. male with a known history of severe COPD and type 2 diabetes mellitus. He came to my office with a several day history of increasing shortness of breath. He had increased his oral steroids and breathing treatments at home and despite this was still having oxygen saturations in the low to mid 80s on 2-4 L of supplemental oxygen. In my office he was extremely diminished and had basically failed outpatient therapy. Therefore he was admitted to inpatient status for acute treatment of a severe COPD exacerbation requiring IV antibiotics and IV steroids. He was admitted and treated with IV treatments. He did recover nicely. However, he was found to be extremely physically deconditioned. Because of this he was thought to be an excellent candidate for swing bed and is being transitioned to swing bed. 4/5/21 ER Practitioner Note: Upon arrival to ED trauma room I found patient to be in cardiac arrest, CPR in progress. History is that EMS was called to the scene for a patient with chest pain. Shortly after arrival at his home patient developed a cardiac arrest. They followed standard ACLS protocol and the patient was intubated. Blood sugar normal. As CPR was given, medications were administered consisting of epinephrine and 1 mg in 2 different doses along with 1 amp of bicarb. IV access via an IO. Patient was then transported to the emergency department. Upon arrival, CPR was continued and oxygen supplied via endotracheal tube with good tube placement verified by auscultation and good sat readings. Monitor was placed and patient demonstrated initially a sinus rhythm but there was no pulse. Therefore, diagnosis was PEA and no reversible causes were identified. ACLS protocol was followed with epinephrine 1 mg IV every 5 min. He received a total that including EMS, 5 mg of epinephrine and 1 amp of bicarb. Monitor at this point revealed the rhythm changed to an agonal rhythm. When CPR was given, there was good results from the CPR. However, CPR discontinued and there is no pulse and patient had an agonal rhythm for several minutes, pupils were fixed but not dilated year. Lungs demonstrating clear bilateral breath sounds when he was bagged via the endotracheal tube. No external signs of any trauma noted. The patient''s sister is here and she is a registered nurse. We had discussed management at this point with her and all were in agreement that the code be terminated. At 1015, patient was pronounced deceased.. ACLS protocol was followed. See nursing record for medication and vital sign details. Code outcome: Deceased CC time 20 minutes.

VAERS ID: 1173826 (history)   Form: Version 2.0   Age: 92.0   Sex: Female   Location: Texas   Vaccinated: 2021-03-09 Onset: 2021-03-20    Days after vaccination: 11 Submitted: 0000-00-00 Entered: 2021-04-06 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / IM Administered by: Private       Purchased by: ? Symptoms: Cardiac arrest, Chest pain, Death, Dyspnoea, Fall, X-ray normal SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Respiratory failure (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-03-20    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: Metformin Amlodipine lasix lovastatin meloxicam lisinopril zofran trazodone fenofibrate Current Illness: Preexisting Conditions: Arthritis HTN DM HLD GERD Allergies: KNA Diagnostic Lab Data: CDC Split Type: Write-up: Pt received the vaccine on 3/9/2021 reports to ED on 3/19/2021 s/p fall while transferring from wheelchair no fractures on x-ray, sent home at 2246. started to c/o chest pain and shortness of breath. Went into cardiac arrest at home approximately 4 hours after leaving ER. Pt was pronounced DOA 3/20/201 @ 0343

VAERS ID: 1177248 (history)   Form: Version 2.0   Age: 86.0   Sex: Female   Location: Alabama   Vaccinated: 2021-04-02 Onset: 2021-04-04    Days after vaccination: 2 Submitted: 0000-00-00 Entered: 2021-04-07 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805031 / N/A LA / IM Administered by: Other       Purchased by: ? Symptoms: Cardiac arrest, Chills, Malaise, Pyrexia SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-04-06    Days after onset: 2 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? Yes Hospitalized? Yes, 2 days    Extended hospital stay? No Previous Vaccinations: Other Medications: Alpahgan P 0.1% eye drops Amlodipine 5mg tablet Aspirin 81 mg tablet Delayed release Betimol 0.5% eye drops Calmoseptine 0.44%-20.6% topical ointment Carvedilol 12.5 mg tablet Hydralazine 50mg tablet lidocaine-prilocaine 2.5%-2.5% topical Current Illness: none that I am aware of. Preexisting Conditions: Patient was placed on Hospice care the week of 3/29/2021. Allergies: Betadine- skin rash Diagnostic Lab Data: unknown CDC Split Type: Write-up: Family reports general malaise post treatment, followed by fever and chills 4/3/2021, and cardiac arrest 4/4/2021.

VAERS ID: 1186471 (history)   Form: Version 2.0   Age: 45.0   Sex: Male   Location: Pennsylvania   Vaccinated: 2021-04-07 Onset: 2021-04-09    Days after vaccination: 2 Submitted: 0000-00-00 Entered: 2021-04-09 Vaccin­ation / Manu­facturer Lot / Dose Site / Route COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 202A21A / 1 RA / IM Administered by: Other       Purchased by: ? Symptoms: Asthenia, Cardiac arrest, Cardioversion, Death, Diarrhoea, Hyperhidrosis, Life support, Resuscitation SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Pseudomembranous colitis (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Noninfectious diarrhoea (narrow), Respiratory failure (broad), Hypoglycaemia (broad) Life Threatening? No Birth Defect? No Died? Yes    Date died: 2021-04-09    Days after onset: 0 Permanent Disability? No Recovered? No Office Visit? No ER Visit? No ER or Doctor Visit? No Hospitalized? No Previous Vaccinations: Other Medications: AMLODIPINE 10MG TABLET -- [TAKE 1 TABLET(S) ORALLY ONCE DAILY] -- 2021-02-23--2021-09-20 ATORVASTATIN 40MG TABLET -- [TAKE 1 TABLET(S) ORALLY ONCE DAILY] -- 2021-02-23--2021-09-20 LACTULOSE 10GM/15ML SOL -- [TAKE 30 MILLILITER(S) ORALLY TWI Current Illness: D-4 - POST-OPERATIVE ANALGESIA, MILD-TO-MODERATE - 2020-09-03 E78.5 - HYPERLIPIDEMIA, UNSPECIFIED - 2021-02-23 I10 - HYPERTENSION, UNSPEC. - 2019-02-04 F10.20 - **[F10.20A]** ALCOHOL USE DISORDER, MODERATE - 2019-02-11 F14.20 - **[F14.20A]** COCAINE USE DISORDER, MODERATE - 2019-02-11 D-19 - FRACTURED TOOTH - 2020-08-24 Preexisting Conditions: D-4 - POST-OPERATIVE ANALGESIA, MILD-TO-MODERATE - 2020-09-03 E78.5 - HYPERLIPIDEMIA, UNSPECIFIED - 2021-02-23 I10 - HYPERTENSION, UNSPEC. - 2019-02-04 F10.20 - **[F10.20A]** ALCOHOL USE DISORDER, MODERATE - 2019-02-11 F14.20 - **[F14.20A]** COCAINE USE DISORDER, MODERATE - 2019-02-11 D-19 - FRACTURED TOOTH - 2020-08-24 Allergies: VANCOMYCIN RELATED Diagnostic Lab Data: Resulted on 3/31/2021 FT4 - (NF) FT4 - FT4 L <0.25 (<0.25) 0.78-2.19 ng/dL T3 TOTAL - (NF) T3 TOTAL - T3 TOTAL LL 0.355 (0.355) 0.970-1.69 NG/ML TSH-HIGH SENSITIVITY - (NF) TSH-HIGH SENSITIVITY - TSH-HIGH SENSITIVITY HH 170.783 (171.219) 0.465-4.68 uU/mL CDC Split Type: Write-up: Complaints of diarrhea, sweating, weakness suffered sudden cardiac arrest. CPR, AED, Lucas device applied ACLS protocol initiated by EMS. Efforts terminated. Patient pronounced deceased at 1003am.

New Search